Medscape June 14, 2020
Miriam E. Tucker

The Abbott FreeStyle Libre glucose monitoring system significantly reduced hospitalizations for diabetic ketoacidosis (DKA), diabetes-related emergencies, and all-cause hospitalizations among patients with diabetes, data from two new studies indicate.

The results were presented June 13 during the virtual American Diabetes Association (ADA) 80th Scientific Sessions.

One large database analysis, from France, revealed that use of the Libre system halved hospitalization rates for DKA among people with type 1 or type 2 diabetes.

In the other study, a retrospective analysis of data from over 1200 insulin-treated individuals with type 2 diabetes in the United States, use of the Libre was associated with significant reductions in both hospitalizations for acute diabetes-related emergency events and all-cause hospitalizations.

The Libre system reads...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Digital Health, Health System / Hospital, Patient / Consumer, Physician, Provider, Technology, Wearables
Related Articles:
Your Earphones And Headphones As Health And Medical Devices
Wearable Devices for Parkinson’s Disease: The Future Is Here
Wearable electrical nerve stimulation device eases long COVID pain and fatigue, say researchers
Singapore tackling chronic diseases with wearables
Researchers use fitness tracker data and machine learning to detect bipolar disorder mood swings

Share This Article